Spironolactone And Hydrochlorothiazide

   
Google
 
Web NewDrugInformation.com

Spironolactone And Hydrochlorothiazide


Drug - Spironolactone And Hydrochlorothiazide
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Hydrochlorothiazide; Spironolactone
Multiple ingredients are in alphabetical order.

Strength - 25MG;25MG
The potency of the active ingredient(s), Hydrochlorothiazide; Spironolactone. May repeat for multiple part products.

Applicant - SUPERPHARM
The firm name holding legal responsibility for Spironolactone And Hydrochlorothiazide. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 089137
The FDA assigned number to Spironolactone And Hydrochlorothiazide. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Spironolactone And Hydrochlorothiazide. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Aug 26, 1985
The date Spironolactone And Hydrochlorothiazide was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Spironolactone And Hydrochlorothiazide. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Spironolactone And Hydrochlorothiazide is in. Format is RX, OTC, DISCN.

Applicant Full Name - Superpharm Corp
The full name of the firm holding legal responsibility for the new application of Spironolactone And Hydrochlorothiazide.

Spironolactone And Hydrochlorothiazide